These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24164265)

  • 1. Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.
    Knappe D; Cassone M; Nollmann FI; Otvos L; Hoffmann R
    Protein Pept Lett; 2014 Apr; 21(4):321-9. PubMed ID: 24164265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing naturally occurring glycosylated forms of proline rich antibacterial peptide, Drosocin.
    Lele DS; Kaur G; Thiruvikraman M; Kaur KJ
    Glycoconj J; 2017 Oct; 34(5):613-624. PubMed ID: 28656506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of distal sugar and interglycosidic linkage of disaccharides on the activity of proline rich antimicrobial glycopeptides.
    Lele DS; Dwivedi R; Kumari S; Kaur KJ
    J Pept Sci; 2015 Nov; 21(11):833-44. PubMed ID: 26424213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.
    Lele DS; Talat S; Kumari S; Srivastava N; Kaur KJ
    Eur J Med Chem; 2015 Mar; 92():637-47. PubMed ID: 25617693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity.
    Talat S; Thiruvikraman M; Kumari S; Kaur KJ
    Glycoconj J; 2011 Dec; 28(8-9):537-55. PubMed ID: 21968924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlarged scale chemical synthesis and range of activity of drosocin, an O-glycosylated antibacterial peptide of Drosophila.
    Bulet P; Urge L; Ohresser S; Hetru C; Otvos L
    Eur J Biochem; 1996 May; 238(1):64-9. PubMed ID: 8665953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.
    Berthold N; Czihal P; Fritsche S; Sauer U; Schiffer G; Knappe D; Alber G; Hoffmann R
    Antimicrob Agents Chemother; 2013 Jan; 57(1):402-9. PubMed ID: 23114765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake of apidaecin 1b and related analogs in Gram-negative bacteria reveals novel antibacterial mechanism for proline-rich antimicrobial peptides.
    Berthold N; Hoffmann R
    Protein Pept Lett; 2014 Apr; 21(4):391-8. PubMed ID: 24164266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal oncocin derivatives with superior serum stabilities.
    Knappe D; Kabankov N; Hoffmann R
    Int J Antimicrob Agents; 2011 Feb; 37(2):166-70. PubMed ID: 21185160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
    Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptides: synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues.
    Gobbo M; Biondi L; Filira F; Gennaro R; Benincasa M; Scolaro B; Rocchi R
    J Med Chem; 2002 Sep; 45(20):4494-504. PubMed ID: 12238928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect peptides with improved protease-resistance protect mice against bacterial infection.
    Otvos L; Bokonyi K; Varga I; Otvos BI; Hoffmann R; Ertl HC; Wade JD; McManus AM; Craik DJ; Bulet P
    Protein Sci; 2000 Apr; 9(4):742-9. PubMed ID: 10794416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects.
    Hoffmann R; Bulet P; Urge L; Otvös L
    Biochim Biophys Acta; 1999 Feb; 1426(3):459-67. PubMed ID: 10076062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens.
    Cudic M; Lockatell CV; Johnson DE; Otvos L
    Peptides; 2003 Jun; 24(6):807-20. PubMed ID: 12948832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
    Bluhm ME; Knappe D; Hoffmann R
    Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.
    Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L
    Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antibacterial spectrum of drosocin analogues.
    Bikker FJ; Kaman-van Zanten WE; de Vries-van de Ruit AM; Voskamp-Visser I; van Hooft PA; Mars-Groenendijk RH; de Visser PC; Noort D
    Chem Biol Drug Des; 2006 Sep; 68(3):148-53. PubMed ID: 17062012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel proline-hydroxyproline glycopeptides from the dandelion (Taraxacum officinale Wigg.) flowers: de novo sequencing and biological activity.
    Astafieva AA; Enyenihi AA; Rogozhin EA; Kozlov SA; Grishin EV; Odintsova TI; Zubarev RA; Egorov TA
    Plant Sci; 2015 Sep; 238():323-9. PubMed ID: 26259198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.
    Knappe D; Piantavigna S; Hansen A; Mechler A; Binas A; Nolte O; Martin LL; Hoffmann R
    J Med Chem; 2010 Jul; 53(14):5240-7. PubMed ID: 20565063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.